Answers are grounded in this paper and cite their sources.
Determine if your contract review tool qualifies for the Article 6(3) derogation or faces high-risk classification under the EU AI Act by Aug 2, 2026. Independent technical note mirroring the canonical version: https://lawr.io/blog/contract-review-tools-article-63-derogation-or-high-risk-by-aug-2-2026.php
No takes yet. Share an insight, caveat, or question.
Natalie Fletcher (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: